EP1414500A4 - Akt und regulierung der synovialfibroblasten-apoptosis bei ra - Google Patents
Akt und regulierung der synovialfibroblasten-apoptosis bei raInfo
- Publication number
- EP1414500A4 EP1414500A4 EP02731374A EP02731374A EP1414500A4 EP 1414500 A4 EP1414500 A4 EP 1414500A4 EP 02731374 A EP02731374 A EP 02731374A EP 02731374 A EP02731374 A EP 02731374A EP 1414500 A4 EP1414500 A4 EP 1414500A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- akt
- regulation
- synovial fibroblast
- fibroblast apoptosis
- apoptosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28396601P | 2001-04-16 | 2001-04-16 | |
US283966P | 2001-04-16 | ||
PCT/US2002/011820 WO2002083075A2 (en) | 2001-04-16 | 2002-04-16 | Akt and regulation of ra synovial fibroblast apoptosis |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1414500A2 EP1414500A2 (de) | 2004-05-06 |
EP1414500A4 true EP1414500A4 (de) | 2005-01-12 |
Family
ID=23088331
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02731374A Withdrawn EP1414500A4 (de) | 2001-04-16 | 2002-04-16 | Akt und regulierung der synovialfibroblasten-apoptosis bei ra |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1414500A4 (de) |
CA (1) | CA2444840A1 (de) |
WO (1) | WO2002083075A2 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0201882D0 (en) * | 2002-01-28 | 2002-03-13 | Novartis Ag | Organic compounds |
AU2003295320A1 (en) * | 2002-06-26 | 2004-04-08 | The Ohio State University Research Foundation | The method for reducing inflammation using sti-571 or its salt |
GR20050100526A (el) * | 2005-10-19 | 2007-05-23 | B.S.R.C. "Alexander Fleming" | Απορυθμισμενα γονιδια και/ ή μεθοδοι στην φλεγμονωδη αρθριτιδα. |
EP2177510A1 (de) | 2008-10-17 | 2010-04-21 | Universität des Saarlandes | Allosterische Proteinkinasemodulatoren |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5476851A (en) * | 1994-09-08 | 1995-12-19 | Rhone-Poulenc Rorer Pharmaceuticals, Inc. | Pyrazolo[3,4-g]quinoxaline compounds which inhibit PDGF receptor protein tyrosine kinase |
-
2002
- 2002-04-16 WO PCT/US2002/011820 patent/WO2002083075A2/en not_active Application Discontinuation
- 2002-04-16 EP EP02731374A patent/EP1414500A4/de not_active Withdrawn
- 2002-04-16 CA CA002444840A patent/CA2444840A1/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
No further relevant documents disclosed * |
Also Published As
Publication number | Publication date |
---|---|
EP1414500A2 (de) | 2004-05-06 |
WO2002083075A2 (en) | 2002-10-24 |
CA2444840A1 (en) | 2002-10-24 |
WO2002083075A3 (en) | 2004-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL161384A0 (en) | Bicyclic oxopyridine and oxopyrimidine derivatives | |
HUP0401017A3 (en) | Combination of probiotics | |
AU2002306768A1 (en) | Expression profiles and methods of use | |
HUP0401248A3 (en) | Preparation of aminopyrimidine compounds and new intermediates | |
EP1414841A4 (de) | Oligonukleotidhaltige pharmakologische zusammensetzungen und deren verwendung | |
AU2002315263A1 (en) | Aluminium implant and use thereof | |
AU2002360437A8 (en) | Reducing myelin-mediated inhibition of axon regeneration | |
TW511856U (en) | Adjustable nozzle of tin oven | |
EP1414500A4 (de) | Akt und regulierung der synovialfibroblasten-apoptosis bei ra | |
HUP0500734A3 (en) | Use of 2-alkoxyphenyl-substituted imidazotriazinones | |
IL161178A0 (en) | MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES | |
AU2002352253A8 (en) | Regulation of human sialyltransferase | |
EP1392460A4 (de) | Fluorwasserstoffe von aminosilanolen und ihre verwendung | |
AU7054101A (en) | Regulation of human calcium-independent alpha-latro-toxin-like g protein-coupledreceptor | |
AU2002231741A1 (en) | Regulation of human tau-tubulin kinase | |
GB9819921D0 (en) | Inhibition of fibroblast proliferation | |
TW530575U (en) | Rail of drawer | |
EP1389304A4 (de) | Haftende entitäten und verwendungen dafür | |
GB2365026B (en) | Coating of rails | |
TW422400U (en) | Improvement of transformer | |
TW573531U (en) | Structure of adjustable wheelchair | |
GB9930028D0 (en) | Authentication of designed surfaces | |
HU0104370D0 (en) | Honeyed schnaps of oerseg | |
AU2002333810A1 (en) | Regulation of human tau-tubulin kinase | |
PL112031U1 (en) | Set of furniture segments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20031114 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: HSU, HUI-CHEN Inventor name: YANG, PINGAR Inventor name: LIANG, XU Inventor name: XIE, JIN-FU Inventor name: ZHANG, HUANG-GE Inventor name: MOUNTZ, JOHN, D. |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20041130 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20050215 |